Safety and efficacy of Fel d 1 derived peptide immunotherapy in a double-blind, placebo-controlled environmental exposure chamber study Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- November 1, 2012
has subject area
- 1107 Immunology (FoR)
- Allergy (Science Metrix)